Work

Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCN

Year: 2025

Type: article

Source: Blood Neoplasia

DOI: 10.1016/j.bneo.2025.100086

Authors: Naveen Pemmaraju, Luan Hai Phan, Geoffrey Fell, Marlise R. Luskin, Mahesh Swaminathan, Sherry Pierce, Courtney DiNardo, Abhishek Maiti, Marina Konopleva, Andrew A. Lane

Institutions: The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

Funders: Leukemia and Lymphoma Society, University of Texas MD Anderson Cancer Center, National Cancer Institute

Awards: G111615301, G1468253849, G2169464185, G6526681941

OpenAlex ID: W4408102090

FWCI: 3.269

Cites: 24

Cited by: 5

Related to: 10